These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23340160)

  • 1. Window of opportunity: estrogen as a treatment for ischemic stroke.
    Liu R; Yang SH
    Brain Res; 2013 Jun; 1514():83-90. PubMed ID: 23340160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen, neuroprotection and neurogenesis after ischemic stroke.
    Shao B; Cheng Y; Jin K
    Curr Drug Targets; 2012 Feb; 13(2):188-98. PubMed ID: 22204318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens as neuroprotectants against ischemic stroke.
    Alonso de Leciñana M; Egido JA
    Cerebrovasc Dis; 2006; 21 Suppl 2():48-53. PubMed ID: 16651814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.
    Liu R; Liu Q; He S; Simpkins JW; Yang SH
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1006-12. PubMed ID: 19952306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
    Jover-Mengual T; Castelló-Ruiz M; Burguete MC; Jorques M; López-Morales MA; Aliena-Valero A; Jurado-Rodríguez A; Pérez S; Centeno JM; Miranda FJ; Alborch E; Torregrosa G; Salom JB
    J Steroid Biochem Mol Biol; 2017 Jul; 171():296-304. PubMed ID: 28479229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens as protectants of the neurovascular unit against ischemic stroke.
    Yang SH; Liu R; Perez EJ; Wang X; Simpkins JW
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):169-77. PubMed ID: 15857302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of estrogen efficacy against cerebral ischemia in aged postmenopausal female mice.
    Cai M; Ma YL; Qin P; Li Y; Zhang LX; Nie H; Peng Z; Dong H; Dong HL; Hou WG; Xiong LZ
    Neurosci Lett; 2014 Jan; 558():115-9. PubMed ID: 24246902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hi1a as a Novel Neuroprotective Agent for Ischemic Stroke by Inhibition of Acid-Sensing Ion Channel 1a.
    Ren Y; Li C; Chang J; Wang R; Wang Y; Chu XP
    Transl Stroke Res; 2018 Apr; 9(2):96-98. PubMed ID: 29027122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection for ischemic stroke: past, present and future.
    Ginsberg MD
    Neuropharmacology; 2008 Sep; 55(3):363-89. PubMed ID: 18308347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era.
    Murphy S; McCullough L; Littleton-Kearney M; Hurn P
    Endocrine; 2003 Jun; 21(1):17-26. PubMed ID: 12777699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental therapy approaches for ischemic stroke].
    Kleinschnitz C; Plesnila N
    Nervenarzt; 2012 Oct; 83(10):1275-81. PubMed ID: 23015194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of thrombolytic therapy and neuroprotective therapy in acute ischemic stroke: is it important?
    Wang Y; Li Q; Wang J; Zhuang QK; Zhang YY
    Eur Rev Med Pharmacol Sci; 2015; 19(3):416-22. PubMed ID: 25720713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental neuroprotection in ischemic stroke: a concise review.
    Rajah GB; Ding Y
    Neurosurg Focus; 2017 Apr; 42(4):E2. PubMed ID: 28366067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of estrogens following ischemic stroke.
    Suzuki S; Brown CM; Wise PM
    Front Neuroendocrinol; 2009 Jul; 30(2):201-11. PubMed ID: 19401209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.
    Engler-Chiurazzi EB; Brown CM; Povroznik JM; Simpkins JW
    Prog Neurobiol; 2017 Oct; 157():188-211. PubMed ID: 26891883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection for ischemic stroke: two decades of success and failure.
    Cheng YD; Al-Khoury L; Zivin JA
    NeuroRx; 2004 Jan; 1(1):36-45. PubMed ID: 15717006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.